Galapagos NV Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
Gilead, Galapagos Slide After FDA Rejects Filgotinib Over Toxicity Concerns
Article By: The Fly
Wednesday, August 19, 2020 11:28 AM EDT
Mizuho sees the news as a "clear positive" for both AbbVie and Pfizer.
In this article: GILD, GLPG Also: PFE
Read
Galapagos Sinks After FDA Issues Complete Response Letter To Partner Gilead
Article By: The Fly
Wednesday, August 19, 2020 7:40 AM EDT
Galapagos last night announced that Gilead Sciences received a Complete Response Letter from the FDA for the New Drug Application for filgotinib, an investigational treatment for moderately to severely active rheumatoid arthritis.
In this article: GILD, GLPG
Read
Week In Review: Taimei Raises $212 Million For AI Life Science Support Software
Article By: ChinaBio® Today
Sunday, October 20, 2019 4:00 AM EDT
Deals, financings, trials and approvals in the China bio markets over the past week.
In this article: MPSYF, GLPG
Read
My Favorite Strategies And Stocks For The Long Run In Belgium
Video By: Option Generator
Saturday, March 16, 2019 9:30 PM EDT
In this video, I zero in on my favorite strategies and what Belgian stocks you should own for the long run.
In this video: GLPG Also: SPY, QQQ, DIA
Watch
E ADRs Best & Worst Report - July 11, 2016
Article By: E.B. Capital Markets
Monday, July 11, 2016 9:00 AM EDT
The average ADR is trading -23.76% below its 52 week high, 2.83% above its 200 dma, has 3.72 days to cover held short, and is expected to grow its EPS by 17.58% next year.
In this article: AXS, AZN, BCE, BMO, CEO, CNQ, ECA, GSK, HMY, KEP, KT, NVO, RDY, RY, SHI, SID, SNP, STO, TU, YZC, SUBCY, GOLD, GSOL, AMRN, DRD, GLPG
Read

PARTNER HEADLINES

Latest Tweets for $GLPG

No tweets yet!